Aim Medical devices (medtech) is a strong driver of innovation and new treatments in healthcare. Straddling the fields of engineering and healthcare, successful medtech development demands critical needs assessment, highly skilled medical engineering professionals, and the successful collaboration between medical and other experts. Optimal development and testing need an efficient dialogue with third parties, including regulators and payers. BioInnovate Ireland was established in 2011 as a multidisciplinary, structured programme to shape the future of medical device therapy based on innovation and interdisciplinary cross-fertilisation. Methods and results 107 fellows have completed the programme covering 20 clinical areas. Fellows have funded companies at a rate of more than 1.5 companies per year which have attracted Irish and international seed funding in excess of €40 million, excluding undisclosed investments. Conclusions A multidisciplinary programme targeting mature, experienced professionals can drive a highly successful medtech start-up culture in the right ecosystem.

中文翻译：

---

通过成功的联合学术/商业奖学金推动医疗技术创新和初创公司的成立

Aim 医疗器械 (medtech) 是医疗保健创新和新疗法的强大推动力。跨越工程和医疗保健领域，成功的医疗技术开发需要关键需求评估、高技能的医疗工程专业人员以及医疗和其他专家之间的成功合作。最佳开发和测试需要与第三方（包括监管机构和付款人）进行有效对话。BioInnovate Ireland 成立于 2011 年，是一个多学科、结构化的计划，旨在基于创新和跨学科交叉融合塑造医疗器械治疗的未来。方法和结果 107 名研究员完成了涵盖 20 个临床领域的计划。研究员以超过1的速度资助公司。每年有 5 家公司吸引了超过 4000 万欧元的爱尔兰和国际种子资金，不包括未公开的投资。结论 针对成熟、经验丰富的专业人士的多学科计划可以在正确的生态系统中推动非常成功的医疗技术创业文化。